Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Surgery raises ethical question

Jeremy Laurance
Monday 30 March 1998 17:02 EST
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

THE LIMITS to which people will go in the interests of medical science are to be tested in an extreme trial of a new treatment for Parkinson's disease.

Thirty six patients have volunteered to have holes drilled in their skulls although only half of them will get the treatment - a transplant of brain cells taken from pig foetuses. The untreated group will have the anaesthetic and the operation but will finish up with nothing more than a hole in the head. Ethics experts described the study last night as an example of "scientific fetishism".

The trial has been designed to test the effectiveness of transplanting foetal pig brain cells into people in the advanced stages of the disease. The untreated group will act as controls against which the progress of the treated group can be measured.

Over the next few months, surgeons will drill the holes, the size of a small coin, and implant 12 million foetal pig cells into the brains of half the patients. The remaining half will have small depressions drilled in their skulls. The patients will have no way of knowing whether they have received the pig cells or not.

The study is being conducted by Diacrin, a biomedical company based in Boston, which said the risks were small

But Jason Karlawish of the Centre for Biomedical Ethics at the University of Pennsylvania said: "It is just to see if people respond to having their heads drilled. This is scientific fetishism about exactitude. I would argue it is not good science."

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in